NCT07405476 2026-04-17
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Phase 2 Recruiting
Emory University
National Cancer Institute (NCI)
Medical University of South Carolina
National Cancer Institute (NCI)
Mayo Clinic
SWOG Cancer Research Network